Literature DB >> 28507590

Epithelioid hemangioendothelioma presenting as fever of unknown origin.

Natalia Vallianou1, Aris Kollas1, Nikos Schizas1, Elina Theodorakopoulou1, Elli Tripodaki1, Christina Vourlakou1, Ileanna Mani2, Nikos Ziras2.   

Abstract

Entities:  

Year:  2016        PMID: 28507590      PMCID: PMC5420629          DOI: 10.5114/aoms.2016.64039

Source DB:  PubMed          Journal:  Arch Med Sci        ISSN: 1734-1922            Impact factor:   3.318


× No keyword cloud information.
Epithelioid hemangioendothelioma (EHE) was first described by Weiss and Enzinger in 1982 and has been suggested to be a malignant vascular neoplasm with indolent behavior [1]. A 65-year-old female patient presented to our hospital with fever, back pain and pain in her buttocks. On examination, the only pathological sign were cutaneous nodules appearing in her right thigh (Figure 1 A). The histopathology of the nodule was compatible with epithelioid hemangioendothelioma (Figure 1 B). Positron emission tomography/computed tomography (PET/CT) scan revealed the presence of multiple lesions in various muscle groups as well as the invasion of bone marrow. The patient was referred to the oncology department, where she was treated for an angiosarcoma, with the combination of gemcitabine with docetaxel.
Figure 1

A – One of the cutaneous lesions that became visible and were compatible with epithelioid hemangioendothelioma. B – Hematoxylin and eosin 400×: Tumor consisted of a mixture of slightly pleomorphic spindle and epithelioid cells with abundant, sharply defined eosinophilic cytoplasm and vesicular nuclei containing single nucleoli

A – One of the cutaneous lesions that became visible and were compatible with epithelioid hemangioendothelioma. B – Hematoxylin and eosin 400×: Tumor consisted of a mixture of slightly pleomorphic spindle and epithelioid cells with abundant, sharply defined eosinophilic cytoplasm and vesicular nuclei containing single nucleoli Epithelioid hemangioendothelioma is a vascular neoplasm of endothelial origin, which is considered to be intermediate between hemangioma and angiosarcoma [2]. It usually presents as a solitary, slightly painful papule, nodule or non-healing ulcer. Rarely, it may present as multiple lesions [3]. Epithelioid hemangioendothelioma is CD31, ERG, Fli-1 and factor WIII positive [4]. Occasionally, CD30 expression, although mainly associated with lymphoid malignancies and germ cell tumors, has also been reported in EHEs. This is important for the differential diagnosis, but it may also have therapeutic implications as CD30 positive patients could be candidates for targeted therapy based on the new CD30 antibody agents [5]. In most cases, a definite diagnosis of EHE remains challenging. Chromosomal translocation t(1;3)(p36;q25) is characteristic for EHE, and may serve as a diagnostic tool [1]. To our knowledge, this is the first report of EHE which presented as fever of unknown origin, due to its spread in the bone marrow, a fact that became prominent on PET/CT scan. Thus, this case also highlights the usefulness of PET/CT scan in the diagnostic algorithm of fever of unknown origin.
  5 in total

1.  Cutaneous epithelioid hemangioendothelioma presented as an ulcerated areolar mass.

Authors:  Song Youn Park; Joshua K Lee; Seongmoon Jo; Chang-Hun Huh; Kwang-Hyun Cho; Jung-Im Na
Journal:  J Dermatol       Date:  2013-12-20       Impact factor: 4.005

2.  Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma.

Authors:  M R Mendlick; M Nelson; D Pickering; S L Johansson; T A Seemayer; J R Neff; G Vergara; H Rosenthal; J A Bridge
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

3.  CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases.

Authors:  Meghna Alimchandani; Zeng-Feng Wang; Markku Miettinen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 May-Jun

4.  Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases.

Authors:  Andrea T Deyrup; Mourad Tighiouart; Anthony G Montag; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

5.  Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.

Authors:  Munir R Tanas; Andrea Sboner; Andre M Oliveira; Michele R Erickson-Johnson; Jessica Hespelt; Philip J Hanwright; John Flanagan; Yuling Luo; Kerry Fenwick; Rachael Natrajan; Costas Mitsopoulos; Marketa Zvelebil; Benjamin L Hoch; Sharon W Weiss; Maria Debiec-Rychter; Raf Sciot; Rob B West; Alexander J Lazar; Alan Ashworth; Jorge S Reis-Filho; Christopher J Lord; Mark B Gerstein; Mark A Rubin; Brian P Rubin
Journal:  Sci Transl Med       Date:  2011-08-31       Impact factor: 17.956

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.